TY - JOUR
T1 - Persistent P21CIP1 induction mediates G1 cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells
AU - Wang, Z.
AU - Lee, H. J.
AU - Chai, Y.
AU - Hu, H.
AU - Wang, Lei
AU - Zhang, Y.
AU - Jiang, C.
AU - Lü, J.
PY - 2010
Y1 - 2010
N2 - The induction of G1 cell cycle arrest and apoptosis by second-generation selenium compounds (e.g., methylselenol precursors such as methylseleninic acid, MSeA) may contribute to their anti-cancer activities. We have documented previously induction of G1 arrest and apoptosis by MSeA in association with upregulation of cyclin-dependent kinase inhibitor (CDKI) proteins P21Cip1 and/or P27Kip1 in DU145 prostate cancer cells. However, whether these CDKIs play a critical mediator role in G1 arrest and apoptosis by MSeA has not been addressed. In the present work, we show exposure of p53-mutant DU145 cells to sub-apoptotic concentrations of MSeA induced p21cip1 mRNA (3 h) and protein (6 h) much faster than p27kip1 mRNA (12 h) and protein (12 h). Knocking down of P21Cip1 by siRNA completely abolished G1 arrest induction by MSeA in DU145 cells, yet si-p27 RNA had no attenuation effect on the G1 arrest. Depletion of P21Cip1 alone or both P21Cip1 and P27Kip1 increased MSeA-induced caspase-mediated apoptosis. Immunoprecipitation detected increased binding of P21Cip1 to CDK2 and CDK6 in MSeA-exposed DU145 cells. In DU145 xenografts from mice acutely treated with MSeA p.o., the induction of P21Cip1 was observed at 72 h of daily exposure. In p53-wild type LNCaP PCa cells and p53-null PC-3 PCa cells, MSeA modestly and transiently upregulated P21Cip1 protein level, subsiding to basal level by 24 h, without affecting P27Kip1 abundance in the same duration. Si-p21 RNA knockdown in these cells have only a partial effect to reverse G1 arrest induction by MSeA. Together, our data support persistent, p53-independent, P21Cip1 induction as a critical mediator of MSeA-induced G1 arrest in DU145 PCa cells, however, P21Cip1 induction and G1 arrest were not necessary for, and may antagonize, caspase-mediated apoptosis.
AB - The induction of G1 cell cycle arrest and apoptosis by second-generation selenium compounds (e.g., methylselenol precursors such as methylseleninic acid, MSeA) may contribute to their anti-cancer activities. We have documented previously induction of G1 arrest and apoptosis by MSeA in association with upregulation of cyclin-dependent kinase inhibitor (CDKI) proteins P21Cip1 and/or P27Kip1 in DU145 prostate cancer cells. However, whether these CDKIs play a critical mediator role in G1 arrest and apoptosis by MSeA has not been addressed. In the present work, we show exposure of p53-mutant DU145 cells to sub-apoptotic concentrations of MSeA induced p21cip1 mRNA (3 h) and protein (6 h) much faster than p27kip1 mRNA (12 h) and protein (12 h). Knocking down of P21Cip1 by siRNA completely abolished G1 arrest induction by MSeA in DU145 cells, yet si-p27 RNA had no attenuation effect on the G1 arrest. Depletion of P21Cip1 alone or both P21Cip1 and P27Kip1 increased MSeA-induced caspase-mediated apoptosis. Immunoprecipitation detected increased binding of P21Cip1 to CDK2 and CDK6 in MSeA-exposed DU145 cells. In DU145 xenografts from mice acutely treated with MSeA p.o., the induction of P21Cip1 was observed at 72 h of daily exposure. In p53-wild type LNCaP PCa cells and p53-null PC-3 PCa cells, MSeA modestly and transiently upregulated P21Cip1 protein level, subsiding to basal level by 24 h, without affecting P27Kip1 abundance in the same duration. Si-p21 RNA knockdown in these cells have only a partial effect to reverse G1 arrest induction by MSeA. Together, our data support persistent, p53-independent, P21Cip1 induction as a critical mediator of MSeA-induced G1 arrest in DU145 PCa cells, however, P21Cip1 induction and G1 arrest were not necessary for, and may antagonize, caspase-mediated apoptosis.
KW - G1 arrest
KW - P21Cip1
KW - Prostate cancer
KW - Selenium
KW - siRNA knockdown
UR - http://www.scopus.com/inward/record.url?scp=77952814195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952814195&partnerID=8YFLogxK
U2 - 10.2174/156800910791190238
DO - 10.2174/156800910791190238
M3 - Article
C2 - 20370687
AN - SCOPUS:77952814195
SN - 1568-0096
VL - 10
SP - 307
EP - 318
JO - Current Cancer Drug Targets
JF - Current Cancer Drug Targets
IS - 3
ER -